等待开盘 03-26 09:30:00 美东时间
+0.690
+2.94%
今日重点评级关注:Oppenheimer:维持Corbus制药控股"跑赢大市"评级,目标价从53美元升至57美元;Canaccord Genuity:维持WAVE Life Sciences"买入"评级,目标价从43美元升至52美元
03-11 12:40
TD Cowen analyst Daniel Bergman maintains Corebridge Financial (NYSE:CRBG) with a Buy and lowers the price target from $38 to $35.
03-10 21:06
VERTIV HOLDINGS LLC涨5.47%;Corebridge Financial, Inc.涨4.34%;回声星通信涨4.00%
03-07 07:11
今日重点评级关注:HC Wainwright & Co.:维持NRX Pharmaceuticals"买入"评级,目标价从40美元升至45美元;RBC Capital:维持NUVATION BIO"跑赢大市"评级,目标价从12美元升至13美元
03-04 10:22
最高股息率接近25%!联合健康、诺和诺德、力合必拓等共计131家公司即将分红;投资者可在除息前布局,赚取股息!一文速览派息名单>>
03-02 14:36
今日重点评级关注:巴克莱:维持Vir Biotechnology"超配"评级,目标价从26美元升至30美元;巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从10美元升至11美元
02-26 09:30
Wells Fargo analyst Wesley Carmichael maintains Corebridge Financial (NYSE:CRBG) with a Overweight and lowers the price target from $37 to $36.
02-25 22:20
今日重点评级关注:HC Wainwright & Co.:维持内克塔治疗"买入"评级,目标价从135美元升至165美元;BTIG:维持内克塔治疗"买入"评级,目标价从118美元升至151美元
02-11 11:02
In the latest quarter, 8 analysts provided ratings for Corebridge Financial (NY...
02-11 02:00
Barclays analyst Alex Scott maintains Corebridge Financial (NYSE:CRBG) with a Overweight and lowers the price target from $35 to $34.
02-10 22:26